ConvaTec Neria guard Gebrauchsanweisung Seite 11

Make sure the medication is kept and handled
according to the instructions for the medication.
Avoid contact with used soft cannula (I).
n
Do not change to a new or unknown product
n
without consulting a healthcare professional for
correct handling.
Change the product in consultation with a
n
healthcare professional following the below
recommendations:
- after 12 hours of use with apomorphine,
- after 12 hours of use with immunoglobulins,
- after 18 hours of use with deferoxamine
mesylate,
- after 72 hours of use with foslevodopa/
foscarbidopa,
- after 72 hours of use with morphine,
- after 72 hours of use with saline.
If using a new insertion device and cannula
n
housing (1b), follow illustrations 1 to 10 in this
instruction. Prime and connect the tubing (J)
separately referring to illustrations G, H and I.
STORAGE & DISPOSAL
Store infusion sets in a cool, dry location at room
n
temperature (15-25°C). Do not store infusion sets
in direct sunlight, or in high humidity.
Dispose of the insertion device in a proper sharps
n
container according to local laws.
Dispose of a used infusion set according to local
n
regulations for biohazardous waste.
ADDITIONAL INFORMATION FOR THE
PATIENT
Use an insertion site as recommended by your
n
healthcare professional. Do not use an insertion
site which is infected, swollen, red, irritated,
bruised or is bleeding. Do not insert in an area
with lumps, hard tissue or bumps. Be careful not
to insert into bone or muscle as this may cause
pain, damage the product and affect medication
absorption. Choose an area that does not have
constrictive clothing or other objects that can pull
on the infusion set.
Please refer to your healthcare professional for
n
insertion site rotation
recommendations.
Check the insertion site frequently to ensure that
n
the soft cannula (I) remains firmly in place. If it is
not in place, change to a new product and a new
site. The soft cannula (I) must always be
completely inserted to ensure delivery of the full
amount of medication. If the insertion site
becomes red or inflamed, change to a new
product and a new site.
The product is available with various soft cannula (I)
n
and tubing (J) lengths. Follow the recommendations
of your
appropriate soft cannula (I) and tubing (J) length.
If, during the use of this device or as a result of its
n
use a serious incident has occurred, please report
it to the manufacturer and to your national authority.
ADDITIONAL INFORMATION FOR THE
HEALTHCARE PROFESSIONAL
Please consider treatment and patient specific
n
factors when choosing an insertion site.
The choice of soft cannula length should be
n
based on treatment and patient specific factors
such as physiology and activity level. A too long
soft cannula may result in insertion pain and/or
insertion into a bone or muscle and a too short
soft cannula in leakage or irritation at the insertion
site. In both cases the infusion must be terminat-
ed and treatment should not be resumed until an
and general
infusion set with another soft cannula length is
inserted at a new insertion site.
Please inform the patient about the correct
n
choice of insertion site in relation to the choice of
soft cannula length.
E N G L I S H (e n )
healthcare professional regarding
11